Vanessa Boulanger is the Executive Director of Strategic Partnerships at the Amyloidosis Research Consortium (ARC), a rare disease nonprofit organization dedicated to increasing awareness, accelerating scientific innovation, and advancing treatment options that improve and extend the lives of those with amyloidosis. Vanessa brings over 15 years of experience centering cross-sector collaboration in pursuit of health and social equity to her position at ARC. She serves on a number of leadership committees, embedding ARC’s work in the broader rare disease and public health discourse. Prior to joining the ARC team, Vanessa was the Director of Research at the National Organization for Rare Disorders (NORD) and served as a member of PCORI's Advisory Panel on Rare Disease. She holds an MSc in Global Health and Population from Harvard University and a BA in International Development from Clark University